Julie & Holleman LLP, a preeminent stockholder rights law firm, is investigating the proposed $3.9 billion buyout of Select Medical Holdings Corp. (NYSE: SEM) by a group consisting of key company insiders and private equity firm Welsh Carson Anderson & Stowe (WCAS).
Additional Information
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The company was co-founded by Robert A. Ortenzio and his late father. The company's largest stockholders include Ortenzio and longtime finance head Martin F. Jackson. WCAS is also a longtime investor in Select Medical and has placed multiple representatives on the company's board of directors.
In late 2025, Ortenzio, Jackson, and WCAS proposed to acquire the rest of Select Medical's shares of common stock. Following a brief process, the parties reached a deal on March 2, 2026.
Under the merger agreement, Select Medical's public stockholders will get cashed out for $16.50 per share, while Ortenzio, Jackson, and WCAS will own the soon-to-be private company. The deal is expected to close in mid-2026.
Julie & Holleman, whose attorneys have secured hundreds of millions of dollars in prior cases, is pursuing potential legal claims based on the apparent unfairness of the deal. The firm is concerned about conflicts arising from the fact that key insiders are continuing on with the company while public stockholders are being cashed out for a price that may be well below the company's true value.